Qure.AI eyes IPO after hitting profitability

By tanvi | May 22, 2025

India-based healthtech startup Qure.AI is gearing up for a public listing, but only after it hits profitability next year.

The deets: Qure.AI builds AI tools to help diagnose diseases early, think tuberculosis, lung cancer, and stroke. The startup counts big names like AstraZeneca, Medtronic, and Johnson & Johnson MedTech among its global clients.

Worth noting: Qure.AI is growing fast with 60-70% revenue growth annually, and serving 15 million patients each year.

Zoom out: the global AI-in-healthcare market is booming & it is expected to grow from $14.9 billion in 2024 to $110 billion by 2030. As overburdened healthcare systems turn to automation, Qure.AI’s early detection tools are finding strong global demand.

Bite-sized insights for the everyday investor

no spam, no bs ☝️

Trending News

View All

Tata Elxsi, Infineon to Power India EV Shift

Tata Elxsi and Infineon are teaming up to co-develop EV tech tailored for India—from battery systems to smart inverters. With safety-first designs and a focus on local needs, the duo aims to make India's EVs smarter, safer, and ready for every road and rider.

By tanvi | Jun 19, 2025

News

Polycab India wins ₹6,447 cr BharatNet contract

Polycab India secured a ₹6,447.5 crore contract to build rural broadband infrastructure across Karnataka, Goa, and Puducherry under BSNL’s BharatNet mission. This project boosts India’s digital reach by connecting thousands of villages with high-speed internet.

By tanvi | Jun 19, 2025

News

UGRO Capital acquires Profectus for ₹1,400 cr

UGRO Capital is buying Profectus Capital for ₹1,400 crore in an all-cash deal, boosting its AUM by 29%. The acquisition strengthens UGRO’s MSME lending, expands its loan portfolio, and opens new lender partnerships in emerging markets and embedded finance.

By tanvi | Jun 19, 2025

Filter Coffee - Qure.AI eyes IPO after hitting profitability